Literature DB >> 29340897

Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection.

B Owrangi1, N Masters1, A Kuballa1, C O'Dea1, T L Vollmerhausen1,2, M Katouli3.   

Abstract

Uropathogenic Escherichia coli (UPEC) strains are found in high numbers in the gut of patients with urinary tract infections (UTIs). We hypothesised that in hospitalised patients, UPEC strains might translocate from the gut to the blood stream and that this could be due to the presence of virulence genes (VGs) that are not commonly found in UPEC strains that cause UTI only. To test this, E. coli strains representing 75 dominant clonal groups of UPEC isolated from the blood of hospitalised patients with UTI (urosepsis) (n = 22), hospital-acquired (HA) UTI without blood infection (n = 24) and strains isolated from patients with community-acquired (CA)-UTIs (n = 29) were tested for their adhesion to, invasion and translocation through Caco-2 cells, in addition to the presence of 34 VGs associated with UPEC. Although there were no differences in the rate and degree of translocation among the groups, urosepsis and HA-UTI strains showed significantly higher abilities to adhere (P = 0.0095 and P < 0.0001 respectively) and invade Caco-2 cells than CA-UTI isolates (P = 0.0044, P = 0.0048 respectively). Urosepsis strains also carried significantly more VGs than strains isolated from patients with only UTI and/or CA-UTI isolates. In contrast, the antigen 43 allele RS218 was found more commonly among CA-UTI strains than in the other two groups. These data indicate that UPEC strains, irrespective of their source, are capable of translocating through gut epithelium. However, urosepsis and HA-UTI strains have a much better ability to interact with gut epithelia and have a greater virulence potential than CA-UPEC, which allows them to cause blood infection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29340897     DOI: 10.1007/s10096-017-3176-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  44 in total

1.  Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains.

Authors:  Concetta Restieri; Geneviève Garriss; Marie-Claude Locas; Charles M Dozois
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

Review 2.  Bacterial manipulation of innate immunity to promote infection.

Authors:  Lautaro Diacovich; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2010-02       Impact factor: 60.633

3.  Differentiation of Escherichia coli pathotypes by oligonucleotide spotted array.

Authors:  Raghavan U M Palaniappan; Yu Zhang; David Chiu; Alfonso Torres; Chobi Debroy; Thomas S Whittam; Yung-Fu Chang
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Comparison between virulence characteristics of dominant and non-dominant Escherichia coli strains of the gut and their interaction with Caco-2 cells.

Authors:  B Owrangi; N Masters; T L Vollmerhausen; C O'Dea; A Kuballa; M Katouli
Journal:  Microb Pathog       Date:  2017-02-22       Impact factor: 3.738

5.  Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia.

Authors:  J N Maslow; M E Mulligan; K S Adams; J C Justis; R D Arbeit
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

6.  Bacterial penetration of bladder epithelium through lipid rafts.

Authors:  Matthew J Duncan; Guojie Li; Jeoung-Sook Shin; Johnny L Carson; Soman N Abraham
Journal:  J Biol Chem       Date:  2004-02-19       Impact factor: 5.157

7.  Between community and hospital: healthcare-associated gram-negative bacteremia among hospitalized patients.

Authors:  Jonas Marschall; Victoria J Fraser; Joshua Doherty; David K Warren
Journal:  Infect Control Hosp Epidemiol       Date:  2009-11       Impact factor: 3.254

8.  Genomic analysis of extra-intestinal pathogenic Escherichia coli urosepsis.

Authors:  A McNally; F Alhashash; M Collins; A Alqasim; K Paszckiewicz; V Weston; M Diggle
Journal:  Clin Microbiol Infect       Date:  2013-04-10       Impact factor: 8.067

Review 9.  Food deprivation increases bacterial translocation after non-lethal haemorrhage in rats.

Authors:  T Bark; M Katouli; T Svenberg; O Ljungqvist
Journal:  Eur J Surg       Date:  1995-02

10.  Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin.

Authors:  Line Skjøt-Rasmussen; Karen Ejrnæs; Bettina Lundgren; Anette M Hammerum; Niels Frimodt-Møller
Journal:  Int J Med Microbiol       Date:  2012-05-08       Impact factor: 3.473

View more
  7 in total

1.  Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics.

Authors:  Ana Paula Daga; Vanessa Lumi Koga; João Gabriel Material Soncini; Caroline Martins de Matos; Marcia Regina Eches Perugini; Marsileni Pelisson; Renata Katsuko T Kobayashi; Eliana Carolina Vespero
Journal:  Front Cell Infect Microbiol       Date:  2019-06-06       Impact factor: 5.293

2.  Genetic and Virulence Characteristics of a Hybrid Atypical Enteropathogenic and Uropathogenic Escherichia coli (aEPEC/UPEC) Strain.

Authors:  Tiago B Valiatti; Fernanda F Santos; Ana C M Santos; Júllia A S Nascimento; Rosa M Silva; Eneas Carvalho; Rita Sinigaglia; Tânia A T Gomes
Journal:  Front Cell Infect Microbiol       Date:  2020-09-29       Impact factor: 5.293

3.  Genetic Characterization of Multidrug-Resistant E. coli Isolates from Bloodstream Infections in Lithuania.

Authors:  Tatjana Kirtikliene; Aistė Mierauskaitė; Ilona Razmienė; Nomeda Kuisiene
Journal:  Microorganisms       Date:  2022-02-15

Review 4.  How Advanced Is Our Understanding of the Role of Intestinal Barrier Dysfunction in the Pathogenesis of Recurrent Urinary Tract Infections.

Authors:  Natalia Stepanova
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

5.  Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli Infections.

Authors:  Laurent Chorro; Zhenghui Li; Ling Chu; Suddham Singh; Jianxin Gu; Jin-Hwan Kim; Kaushik Dutta; Rosalind Pan; Srinivas Kodali; Duston Ndreu; Axay Patel; Julio C Hawkins; Chris Ponce; Natalie Silmon de Monerri; David Keeney; Arthur Illenberger; C Hal Jones; Lubomira Andrew; Jason Lotvin; A Krishna Prasad; Isis Kanevsky; Kathrin U Jansen; Annaliesa S Anderson; Robert G K Donald
Journal:  Infect Immun       Date:  2022-03-21       Impact factor: 3.609

6.  Role of aggregate-forming pilus (AFP) in adherence and colonization of both intestinal and urinary tracts.

Authors:  Paulo A Schüroff; Cecilia M Abe; Jonatas W Silva; Cidéli de Paula Coelho; Fernanda B Andrade; Rodrigo T Hernandes; Ulrich Dobrindt; Tânia A T Gomes; Waldir P Elias
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

7.  Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients.

Authors:  Mohammad Mohammadzadeh; Mahnaz Tavakoli; Somayeh Yaslianifard; Ehsan Asadi; Reza Golmohammadi; Reza Mirnejad
Journal:  Infect Drug Resist       Date:  2019-07-09       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.